Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM.
Secure &
defend your assets
Structure & drive
your IP strategy
Evaluate & leverage
your assets
Support strategic
operations
Industry and
Engineering
Digital
and Networks
Chemistry and
Life Sciences
Retail, Consumer Goods
and Entertainment
About us
International
Digital services
Careers
Our news
Insights
Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM.
Isabelle Thill, Emmanuelle Lev...
ByJérôme Collin will moderate th...
Esther Dupain will be present ...
By